clinical trial · NCT01011205
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
Liver TransplantationAdvagrafMycophenolate MofetilBasiliximabCorticosteroids
brief summary
Comparison of 3 dosing regimens of Advagraf to determine if there is a dosing regimen which may have the potential to cause fewer kidney problems.
started
Sep 30, 2009
primary completion
Jan 4, 2013
completion
Jan 4, 2013
last updated
Nov 1, 2024
official title
A Multicenter, Three Arm, Randomized, Open Label Clinical Study to Compare Renal Function in Liver Transplant Recipients Receiving an Immunosuppressive Regimen of Advagraf (Immediately or Delayed Post-transplant) and MMF With or Without a Monoclonal Anti-IL2R Antibody (Basiliximab)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol